Escalation in specific populations
. E.g. post-neoadjuvant study design show that it is possible to target very
specific populations for escalation based even on conventional pathologic
criteria.
Asian
32% triple negative
6 – 8 cycles
capecitabine 1250
mg/m2 twice daily d1-
d14 q 3wk




